Darla J. Christopher

FDA investigator

Appears on 10 documents from 2010 to 2020, mostly at sites in Texas. Most often cites design and construction features (21 CFR 211.42).

10
Documents on file
6.8
Observations per 483
2010
First seen
2020
Most recent

What they cite most

From 61 observations

Activity by year

2010: 1, 2014: 4, 2015: 2, 2016: 1, 2017: 1, 2020: 1

Where

Texas 9 · California 1

Is Darla J. Christopher coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

10 documents, newest first
FirmOpen
483 QuVa Pharma, Inc.Feb 5, 2020 · Sugar Land, Texas
483 California Stem Cell Treatment Center/Cell Surgical NetworkJul 27, 2017 · Beverly Hills, California
Amended 483 QuVa Pharma, Inc.Mar 12, 2016 · Sugar Land, Texas
483 Elkhart PharmacyDec 21, 2015 · Elkhart, Texas
483 Talon Compounding PharmacyJun 24, 2015 · San Antonio, Texas
483 Walgreens Infusion ServicesNov 25, 2014 · Houston, Texas
Response NuVision PharmacyAug 6, 2014 · Dallas, Texas

About this profile

What does Darla J. Christopher inspect?

Darla J. Christopher appears on 10 documents on file covering 8 sites, mostly in Texas.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.113 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Darla J. Christopher is dated Feb 5, 2020.

FDA Investigator Darla J. Christopher: 483s & Inspections · FDA Intel